Natalja Eigėlienė

587 total citations
12 papers, 153 citations indexed

About

Natalja Eigėlienė is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Natalja Eigėlienė has authored 12 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Natalja Eigėlienė's work include Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Cells and Metastasis (3 papers). Natalja Eigėlienė is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Cells and Metastasis (3 papers). Natalja Eigėlienė collaborates with scholars based in Finland, Sweden and Australia. Natalja Eigėlienė's co-authors include Antti Jekunen, Jatta Saarenheimo, Heidi Andersén, Marja Tiirola, Pirkko Härkönen, Jenni E. Keskitalo, Kalervo Väänänen, Ilkka Koskivuo, Lauri Kangas and Kaisa K. Ivaska and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Oncology and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Natalja Eigėlienė

11 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalja Eigėlienė Finland	9	82	74	67	45	19	12	153
I. Figueiredo United Kingdom	4	117 1.4×	123 1.7×	88 1.3×	91 2.0×	18 0.9×	8	228
Pablo Tolosa Spain	8	50 0.6×	91 1.2×	154 2.3×	61 1.4×	30 1.6×	36	229
Claudette Falato Spain	10	107 1.3×	78 1.1×	161 2.4×	78 1.7×	25 1.3×	20	261
Anna Bellmunt Spain	3	72 0.9×	43 0.6×	135 2.0×	106 2.4×	18 0.9×	4	229
Till Eichenauer Germany	8	64 0.8×	123 1.7×	55 0.8×	125 2.8×	22 1.2×	13	211
Maitri Kalra United States	6	28 0.3×	37 0.5×	84 1.3×	65 1.4×	14 0.7×	22	164
Guangzheng Deng China	7	106 1.3×	61 0.8×	135 2.0×	129 2.9×	30 1.6×	9	282
Brigitte Sigal France	5	109 1.3×	40 0.5×	83 1.2×	43 1.0×	13 0.7×	9	160
Yongjie Xie China	7	49 0.6×	39 0.5×	72 1.1×	72 1.6×	11 0.6×	31	174
Zixin Guo China	9	99 1.2×	129 1.7×	59 0.9×	111 2.5×	11 0.6×	19	220

Countries citing papers authored by Natalja Eigėlienė

Since Specialization

Citations

This map shows the geographic impact of Natalja Eigėlienė's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalja Eigėlienė with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalja Eigėlienė more than expected).

Fields of papers citing papers by Natalja Eigėlienė

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalja Eigėlienė. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalja Eigėlienė. The network helps show where Natalja Eigėlienė may publish in the future.

Co-authorship network of co-authors of Natalja Eigėlienė

This figure shows the co-authorship network connecting the top 25 collaborators of Natalja Eigėlienė. A scholar is included among the top collaborators of Natalja Eigėlienė based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalja Eigėlienė. Natalja Eigėlienė is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Hamilton, Erika, Jee Hyun Kim, Natalja Eigėlienė, et al.. (2023). Efficacy and safety results by age in monarchE: Adjuvant abemaciclib combined with endocrine therapy (ET) in patients with HR+, HER2-, node-positive, high-risk early breast cancer (EBC).. Journal of Clinical Oncology. 41(16_suppl). 501–501. 10 indexed citations

Eigėlienė, Natalja, et al.. (2022). Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT. Radiation Oncology. 17(1). 19–19. 8 indexed citations

Saarenheimo, Jatta, Natalja Eigėlienė, Gajja S. Salomons, et al.. (2021). Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population. Cancer Chemotherapy and Pharmacology. 87(5). 657–663. 12 indexed citations

Saarenheimo, Jatta, Heidi Andersén, Natalja Eigėlienė, & Antti Jekunen. (2021). Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer – A Systematic Review. Frontiers in Oncology. 11. 754427–754427. 6 indexed citations

Eigėlienė, Natalja, et al.. (2021). Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment. Case Reports in Oncology. 14(3). 1475–1482.

Saarenheimo, Jatta, Heidi Andersén, Natalja Eigėlienė, & Antti Jekunen. (2021). Current challenges in applying gene-driven therapies in clinical lung cancer practice. World Journal of Clinical Oncology. 12(8). 656–663. 2 indexed citations

Toriseva, Mervi, Ahmed Maher, Natalja Eigėlienė, et al.. (2020). Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures. Cellular Oncology. 44(1). 205–218. 11 indexed citations

Eigėlienė, Natalja, et al.. (2020). Recent clinical evidence on metronomic dosing in controlled clinical trials: a systematic literature review. Acta Oncologica. 59(7). 775–785. 8 indexed citations

Saarenheimo, Jatta, Natalja Eigėlienė, Heidi Andersén, Marja Tiirola, & Antti Jekunen. (2019). The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer. Frontiers in Oncology. 9. 129–129. 62 indexed citations

10.

Eigėlienė, Natalja, Jatta Saarenheimo, & Antti Jekunen. (2019). Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment. Oncology. 96(3). 115–124. 16 indexed citations

11.

Boström, Pia, Annele Sainio, Natalja Eigėlienė, et al.. (2017). Human Metaplastic Breast Carcinoma and Decorin. Cancer Microenvironment. 10(1-3). 39–48. 8 indexed citations

12.

Kangas, Lauri, Pirkko Härkönen, Kalervo Väänänen, Jenni E. Keskitalo, & Natalja Eigėlienė. (2014). Effects of Ospemifene on Breast Tissue Morphology and Proliferation: A Comparative Study Versus Other Selective Estrogen Receptor Modulators in Ovariectomized Rats. Hormone and Metabolic Research. 46(5). 328–332. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact